Literature DB >> 12572877

Polymorphisms of the IL-1beta and IL-1beta-inducible genes in ulcerative colitis.

Hiroaki Nohara1, Yuki Saito, Singo Higaki, Naoko Okayama, Yuichiro Hamanaka, Kiwamu Okita, Yuji Hinoda.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is a chronic disorder of undetermined etiology, but a genetic predisposition to UC is well recognized. Among cytokines induced in UC, interleukin 1 (IL-1) appears to have a central role because of its immunological upregulatory and proinflammatory activities. The aim of this study was to assess whether UC is associated with polymorphisms of the IL-1beta gene and three additional genes inducible with IL-1beta in Japanese subjects.
METHODS: A total of 96 patients with UC and 106 ethnically matched controls were genotyped at polymorphic sites in IL-1beta, matrix metalloproteinase 1 (MMP-1), matrix metalloproteinase 3 (MMP-3), and inducible nitric oxide synthase (iNOS) genes, using polymerase chain reaction (PCR)-based methods.
RESULTS: There was no significant difference in genotype distributions of IL-1beta, MMP-1, MMP-3, and iNOS genes between controls and UC patients in a Japanese population. Also, no significant association of those polymorphisms with various clinical parameters of the patients was found. However, concerning association of age at onset with clinical factors in UC, the frequency of pancolitis was significantly higher in UC patients with age at onset being less than 30 years than in those more than 30 years of age (P = 0.049).
CONCLUSIONS: No association of the IL-1beta and three IL-1beta-inducible gene polymorphisms with UC was observed in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12572877     DOI: 10.1007/BF03326427

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  18 in total

1.  IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease.

Authors:  A Nemetz; M P Nosti-Escanilla; T Molnár; A Köpe; A Kovács; J Fehér; Z Tulassay; F Nagy; M A García-González; A S Peña
Journal:  Immunogenetics       Date:  1999-06       Impact factor: 2.846

2.  Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease.

Authors:  A Nemetz; A Köpe; T Molnár; A Kovács; J Fehér; Z Tulassay; F Nagy; M A García-González; A S Peña
Journal:  Scand J Gastroenterol       Date:  1999-02       Impact factor: 2.423

Review 3.  Cytokine gene polymorphism in human disease: on-line databases, supplement 1.

Authors:  J Bidwell; L Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  2001-04       Impact factor: 2.676

4.  Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis.

Authors:  A Bitton; M A Peppercorn; D A Antonioli; J L Niles; S Shah; A Bousvaros; B Ransil; G Wild; A Cohen; M D Edwardes; A C Stevens
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

5.  Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.

Authors:  D Heresbach; M Alizadeh; A Dabadie; N Le Berre; J F Colombel; J Yaouanq; J F Bretagne; G Semana
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

6.  Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals.

Authors:  O Mwantembe; M C Gaillard; M Barkhuizen; V Pillay; S D Berry; J B Dewar; E Song
Journal:  Immunogenetics       Date:  2001       Impact factor: 2.846

7.  Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer.

Authors:  L Dunleavey; S Beyzade; S Ye
Journal:  Matrix Biol       Date:  2000-05       Impact factor: 11.583

8.  A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro.

Authors:  F Pociot; J Mølvig; L Wogensen; H Worsaae; J Nerup
Journal:  Eur J Clin Invest       Date:  1992-06       Impact factor: 4.686

9.  Familial occurrence of inflammatory bowel disease.

Authors:  M Orholm; P Munkholm; E Langholz; O H Nielsen; T I Sørensen; V Binder
Journal:  N Engl J Med       Date:  1991-01-10       Impact factor: 91.245

10.  Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.

Authors:  P C Stokkers; B E van Aken; N Basoski; P H Reitsma; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

View more
  2 in total

1.  Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Authors:  Nasser Ebrahimi Daryani; Maryam Sadr; Shirin Moossavi; Sepideh Shahkarami; Samaneh Soltani; Elham Farhadi; Nima Rezaei
Journal:  Dig Dis Sci       Date:  2014-12-03       Impact factor: 3.199

2.  Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.

Authors:  Martin J W Meijer; Marij A C Mieremet-Ooms; Ruud A van Hogezand; Cornelis B H W Lamers; Daniel W Hommes; Hein W Verspaget
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.